AdvertisementHospitals use a lottery to allocate scarce COVID drugs for the immunocompromisedPlay03:51Download AudioJanuary 25, 2022Pien HuangfacebookEmailEvusheld is a treatment authorized for prevention of COVID-19 in people who are seriously immunocompromised or who have had serious adverse reactions to COVID-19 vaccines. (Peter Bostrom/AstraZeneca)
